These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The lengthening handshake. Osborne R Nat Biotechnol; 2010 Mar; 28(3):197-9. PubMed ID: 20212476 [No Abstract] [Full Text] [Related]
29. When times get tough. Jong S Nat Biotechnol; 2009 Mar; 27(3):226-8. PubMed ID: 19274868 [No Abstract] [Full Text] [Related]
30. A time for growth: an interview with Amgen CEO Kevin Sharer. Interview by Paul Hemp. Sharer K Harv Bus Rev; 2004; 82(7-8):66-74, 186. PubMed ID: 15241953 [TBL] [Abstract][Full Text] [Related]
31. BIO marches to Congress with growth package in hand. Carey K Nat Biotechnol; 2011 Sep; 29(9):776-7. PubMed ID: 21904306 [No Abstract] [Full Text] [Related]
32. Biotech industry faces new bottleneck. Garber K Nat Biotechnol; 2001 Mar; 19(3):184-5. PubMed ID: 11231516 [No Abstract] [Full Text] [Related]
39. Italian biotech too reliant on big pharma. Meldolesi A Nat Biotechnol; 2004 Aug; 22(8):1047. PubMed ID: 15309759 [No Abstract] [Full Text] [Related]
40. Is Elan a turnaround? Jacobs T Nat Biotechnol; 2003 Sep; 21(9):985. PubMed ID: 12949557 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]